Distal Aortic and Peripheral Arterial Aneurysms in Patients With Marfan Syndrome  by Yetman, Anji T. et al.
c
a
u
c
f
p
t
n
p
m
l
a
c
F
W
n
w
c
v
v
m
a
r
m
p
2
w
r
f
a
u
r
p
s
a
i
4
1
d
Journal of the American College of Cardiology Vol. 58, No. 24, 2011
© 2011 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00
Published by Elsevier Inc.CORRESPONDENCE
Research
Correspondence Distal Aortic and Peripheral Arterial Aneurysmsin Patients With Marfan SyndromeTo the Editor: The mainstay of clinical surveillance for the
unoperated patient with Marfan syndrome (MFS) is echocardiog-
raphy. Because the aorta is not routinely imaged beyond its
ascending component, the overall incidence of distal or peripheral
arterial disease in MFS is unknown. We sought to determine the
incidence of such disease in adults (age 18 years) with MFS.
Patients were diagnosed in accordance with established clinical
riteria (1), had been receiving routine cardiac care in a regional
ortopathy clinic during 2000 to 2010 for 3 months, and
nderwent 1 magnetic resonance angiography (MRA)/
omputed tomography angiography (CTA) evaluation of the aorta
rom the skull base to iliac bifurcation per our routine clinical
rotocol. Additional imaging of cerebral vessels was performed at
he ordering cardiologist’s discretion in a subset of patients with
onfocal neurological symptoms or when disease of the cervicoce-
halic vessels was noted. Genetic testing for TGFBRI/TGFBRII
utations was performed in all patients with distal disease without
ens subluxation, to rule out Loeys-Dietz syndrome, a related
ortopathy with diffuse arterial involvement (1).
Clinical data in those with and without distal disease were
ompared. Nominal data were analyzed with a chi-square test or
isher exact test. Continuous variables were analyzed with a Mann
hitney U test as their distributions were found to be non-
ormal. Relative risk ratios with 95% confidence intervals (CIs)
ere calculated. Logistic regression was used to control for potential
onfounders using the backward conditional approach for removal of
ariables from the model. Analyses were performed using SPSS
ersion 18.0 (SPSS Inc, Chicago, Illinois). Data are presented as
eans with SDs or medians with ranges as appropriate.
MRA/CTA of the thoraco-abdominal aorta was performed in
ll 140 adults with MFS who met inclusion criteria. Previous aortic
oot replacement had been performed in 73 (52%) patients at a
edian age of 24 (11 to 59) years. Surgery was elective in 62
atients (85%). Of the remaining 11 patients with prior dissection,
had residual dissection of the thoraco-abdominal aorta, which
as not addressed initially. Of the patients undergoing elective
epair, 43% underwent a valve-sparing procedure. Patients were
ollowed up for up to 20 years after aortic root replacement.
MRA/CTA imaging was used to identify 47 distal or peripheral
neurysms in 44 of 140 (31%) patients. Fourteen patients (10%)
nderwent additional imaging of the intracranial vessels. Aneu-
ysms were noted in the native ascending aorta contiguous with the
rior aortic graft in 5 patients, aortic arch in 4, carotid in 6,
ubclavian artery in 4, descending thoracic aorta in 13, abdominal
orta or branch vessels in 3, iliac arteries in 2, and cerebral vessels
n 5. Dissection of the distal/peripheral aneurysm occurred in 32 of
7 aneurysms (68%) and was fatal in 6. During routine follow-up,
3 patients (9%) sought emergent care for symptomatic distal
issection in the face of an aortic root diameter, which had not yetattained surgical criteria (median aortic root diameter: 38 [33 to
45] mm).
Patients with distal/peripheral aneurysms were older (35.5 [18
to 71] years vs. 30 [18 to 64] years; p 0.04) and were more likely
to have undergone prior aortic root replacement (Table 1). Distal
disease was, however, present in approximately one-quarter of
patients who had not had prior aortic root surgery and did not
meet surgical criteria for such. Despite the greater likelihood of
having had prior aortic replacement, the maximal attained aortic
root diameter did not relate to the presence of distal disease.
Although there was no difference between groups when assessing
for the use of any antihypertensive agent, those patients with
distal/peripheral aneurysms were less likely to be receiving an
angiotensin-converting enzyme (ACE) inhibitor at the time of
confirmatory MRA/CTA. There was no relationship between
ACE inhibitor use and age, previous surgery, or other clinical
variables. Patients with distal/peripheral aneurysms had a greater
number of risk factors for acquired heart disease and were 14.9
times (95% CI: 1.75 to 127.21; p  0.01) more likely to die than
those without such aneurysms when controlling for smoking (odds
ratio: 5.09 [95% CI: 1.07 to 24.31]; p 0.04). After controlling for
the presence of a distal/peripheral aneurysm, other variables
(including age, family history of dissection, hypertension, hyper-
lipidemia, prior aortic surgery, and prior ascending aortic dissec-
tion) did not contribute to the model significantly and were
removed. No patient died secondary to complications related to the
ascending aorta. Treatments used for distal aneurysms varied
according to aneurysm site. In general, aneurysms were observed
serially, and if progressive in size, symptomatic, or if published
surgical size criteria were met (2), surgical or percutaneous inter-
vention was used. Of the 47 aneurysms noted, 26 (55%) required
intervention.
This study demonstrated distal/peripheral arterial aneurysms in
approximately one-third of adults with MFS. In keeping with
prior publications (2), smoking, hypertension, and hyperlipidemia
correlated with a greater likelihood of distal/peripheral aortic
disease. Given the study sample size, the multivariate model may
be limited by overfitting.
The incidence of cerebrovascular aneurysms was high at 36% in
a select cohort of patients who underwent cerebral imaging.
Although aneurysms of carotid arteries have been described in
patients with TGFBRI/TGFBRII defects, they have not been
previously noted in association with isolated FBN-1 mutations. An
unexpected finding in our study was the significantly lower
incidence of distal/peripheral disease in patients undergoing ACE
inhibitor therapy. Previous studies have demonstrated a lack of
protective effect of beta-blockade on the development of distal
disease in patients with MFS (3), but to date, no other medical
therapies have been studied.
R2545JACC Vol. 58, No. 24, 2011 Correspondence
December 6, 2011:2544–9This study highlights the changing clinical picture of MFS.
Although the literature still notes dissection of the ascending aorta
to be the primary cause of death in patients with MFS (4), our data
would suggest that those patients with a known diagnosis who
receive routine cardiac care do not succumb to complications
related to the ascending aorta but rather face ongoing morbidity
and mortality related to distal or peripheral arterial disease.
Surveillance of the distal aorta and branches is warranted in all
adults with MFS.
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Clinical Factors Associated With Distal DiseaseTable 1 Clinical Factors Associated With Distal Disease
Variable
Distal Disease
(n  44)
Smoking (%) 9 (21)
Hypertension (%) 18 (41)
Hyperlipidemia (%) 14 (32)
Not receiving an ACE inhibitor (%) 43 (98)
Maximal aortic root size on echocardiogram (mm) 47 (32–71)
Prior aortic root replacement (%) 30 (68)
Time from root replacement (yrs) 8 (1–22)
Distal dissection (%) 32 (71)
Death (%) 6 (14)
Values are n (%) or median (range), unless otherwise indicated.Melanie D. Everitt, MD
cardiac surgeons. At our institution, we perform ultrasound ofdoi:10.1016/j.jacc.2011.09.024
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and Stroke in Patients After
Coronary Artery Bypass
Graft Surgery
We read with interest the paper by Lee et al. (1) on the
influence of cerebral atherosclerosis and stroke after coronary
artery bypass surgery (CABG). Interestingly, they demon-
strated that two-thirds of the patients undergoing CABG
(65.4%) had steno-occlusive lesions in the intracranial and/or
extracranial cerebral arteries. Thus, the issue of cerebrovascular
disease and postoperative neurological complications is very
important in these patients, and awareness is mandatory for thethe carotid arteries as a routine checkup before CABG surgery.
If we have evidence of neurovascular disease, we modify the
anesthesiological management (e.g., keep mean arterial pressure
higher during extracorporeal circulation), the patient monitor-
ing (cerebral near-infrared spectrometry), and surgical manage-
ment (e.g., epiaortic ultrasound, aortic “no-touch” techniques).
Our first question for the authors is: Was the perioperative
management adapted in patients with (more severe) cerebro-
vascular disease?
In one of our studies, we found that atherosclerosis of the
ascending aorta, as determined by intraoperative epiaortic ultra-
sound, was a risk factor for strokes and during mid-term follow-up
of CABG patients (2). Furthermore, ascending aortic atheroscle-
rosis adversely affected long-term survival after CABG (3). Our
second question for the authors is: Did (severe) atherosclerosis of
the aortic arch and/or the ascending aorta have an impact on
post-CABG strokes?
